John Petricciani, MD
Senior Vice President, Medical and Regulatory Affairs at CancerVax Corporation. From 1992-1997, Dr. Petricciani served as VP, Regulatory Affairs at Genetics Institute, Inc. Prior to that, Dr. Petricciani held senior positions in the public an private sectors, including the FDA from 1973-1985, where he served as Director of the Office of Biologics, and the NIH from 1968-1972.
Richard Whitley, MD
He is a distinguished Professor of Pediatrics, Microbiology, Medicine and Neurosurgery at the University of Alabama at Birmingham (UAB). Dr. Whitley also serves as vice-chair of the Department of Pediatrics, is the co-Director of the Center for Biodefense and Emerging Infections at UAB and was a past President of the Infectious Disease Society of America (IDSA). Dr. Whitley is one of the leading figures in the field of virology and infectious disease, and is internationally recognized for his contributions in antiviral research and the engineering of herpes simplex virus for gene therapy. He has served as author and co-author of more than 525 scientific writings in books and peer-reviewed scientific and medical journals. He is editor of Antiviral Research, and associate editor of the Journal of Infectious Diseases and Therapy. Dr. Whitley serves on numerous government and industry advisory committees, including VERBAC (FDA Vaccine Advisory Committee), the Board of Scientific Councilors for NIAID and on the working group for the Presidential Council of Advisors on Science and Technology (PCAST).